Advertisement
Screener

INMUNE BIO INC. (INMB) Accounts Payable, Related Parties, Current

2.8 / 5 stars · 68/120 Roast Me

INMUNE BIO INC. Accounts Payable, Related Parties, Current

INMUNE BIO INC. (INMB) had Accounts Payable, Related Parties, Current of $9.00 thousand as of 2022-12-31, per its 10-K filed 2023-03-02.

Discontinued › Notes › Payables and Accruals

us-gaap:AccountsPayableRelatedPartiesCurrent · last filed 2023-03-02

  • 2022-12-31: Accounts Payable, Related Parties, Current $9.00K.
  • 2022-09-30: Accounts Payable, Related Parties, Current $8.00K.
  • 2022-06-30: Accounts Payable, Related Parties, Current $9.00K.
  • 2022-03-31: Accounts Payable, Related Parties, Current $9.00K.
Period endAccounts Payable, Related Parties, CurrentAccounts Payable, Related Parties, Current as first filed
2022-12-31$9.00K
10-K · filed 2023-03-02
2022-09-30$8.00K
10-Q · filed 2022-11-02
2022-06-30$9.00K
10-Q · filed 2022-08-03
2022-03-31$9.00K
10-Q · filed 2022-05-05
2021-12-31$80.00K
10-K · filed 2023-03-02
2021-09-30$10.00K
10-Q · filed 2021-11-03
2021-06-30$9.00K
10-Q · filed 2021-08-04
2021-03-31$10.00K
10-Q · filed 2021-05-05
2020-12-31$34.00K
10-K · filed 2022-03-03
$33.66K
10-K · filed 2021-03-04
2020-09-30$9.13K
10-Q · filed 2020-11-05
2020-06-30$223.56K
10-Q · filed 2020-08-05
2020-03-31$102.89K
10-Q · filed 2020-05-14
2019-12-31$290.10K
10-K · filed 2021-03-04
2019-09-30$162.11K
10-Q · filed 2019-11-08
2019-06-30$69.89K
10-Q · filed 2019-08-09
2019-03-31$9.22K
10-Q · filed 2019-05-15
2018-12-31$270.55K
10-K · filed 2020-03-11
$9.02K
10-K · filed 2019-03-29
2017-12-31$183.46K
10-K · filed 2019-03-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
ImageneBio, Inc. (IMA)United States$0.056B-1.31
BioAtla, Inc. (BCAB)United States$0.058B-0.21
EXOZYMES INC. (EXOZ)United States$0.058B
Tevogen Inc. (TVGN)United States$0.049B
MiNK Therapeutics, Inc. (INKT)United States$0.063B-5.37
Instil Bio, Inc. (TIL)United States$0.048B-1.73
LeonaBio, Inc. (LONA)United States$0.047B-0.61
Eloxx Pharmaceuticals, Inc. (ELOX)United States$0.065B
Metagenomi Therapeutics, Inc. (MGX)United States$0.044B-0.48
BioStem Technologies, Inc. (BSEM)United States$0.069B